Most Popular Products
Retatrutide 5mg/10mg/15mg/20mg/30mg
100.0 USD ($)/Box
Product Details:
- Taste Other
- Shape Irregular
- Physical Form Powder
- CAS No 2381089-83-2
- Poisonous NO
- Smell Other
- Product Type Peptide Preparations
- Click to View more
X
Retatrutide 5mg/10mg/15mg/20mg/30mg Price And Quantity
- 1 Box
- 100.0 USD ($)/Box
Retatrutide 5mg/10mg/15mg/20mg/30mg Product Specifications
- Freely soluble in water
- 2937190099
- Peptide Preparations
- 1) Triple receptor agonism: Retatrutide is a GGG triple agonist that can act on three receptors simultaneously: glucagon-like peptide-1 receptor (GLP-1R), gastric inhibitory peptide receptor (GIPR) and glucagon receptor (GCGR). This triple mechanism of action makes it excellent in controlling appetite, delaying gastric emptying and increasing energy expenditure. 2) Significant weight loss effect: Clinical trials have shown that Retatrutide is effective in weight loss. At the highest dose, participants lost an average of 24.2% weight in 11 months, which is far superior to the 15-20% weight loss effect of other GLP-1 receptor agonists currently on the market (such as Semaglutide and Tirzepatide). 3) Metabolic regulation: Retatrutide can not only effectively reduce weight, but also improve metabolic indicators. For example, it can significantly reduce glycosylated hemoglobin (HbA1c) levels and has a positive effect on blood sugar control in patients with type 2 diabetes. In addition, it may also have a beneficial effect on cardiovascular health, although this area still needs further research. 4) Long-term effect and convenience: Retatrutide has been modified by fatty acid acylation and can bind to albumin in the blood, thereby extending its half-life. This means that patients only need to inject once a week, which is more convenient to use.
- White or almost white powder
- Freezer
- C221H342N46O68
- Pharmaceutical
- 4730.91
- Irregular
- Powder
- 1) Obesity Treatment: In the Phase II clinical trial, patients in the highest dose group (12 mg) lost an average of 24.2% weight after 48 weeks, and some patients lost more than 30%. 2) Metabolic Dysfunction-Associated Fatty Liver Disease (MASLD): Retatrutide can reduce liver fat content by 86%, and more than 85% of patients achieve regression of liver steatosis. 3) Type 2 Diabetes: Significantly reduce glycated hemoglobin (HbA1c) and improve blood sugar control. 4) Potential Cardiovascular Benefits: Animal studies have shown that it may indirectly protect cardiovascular health by improving blood pressure and heart function, but further clinical verification is needed.
- 99.0%
- Retatrutide
- Other
- 2381089-83-2
- Pharmaceutical Grade
- Other
- NO
- 12 Months
Retatrutide 5mg/10mg/15mg/20mg/30mg Trade Information
- Shanghai, Beijing or Guangzhou
- Paypal Letter of Credit at Sight (Sight L/C) Telegraphic Transfer (T/T) Western Union
- 500 Box Per Week
- 5 Days
- Yes
- If order is confirmed we will reimburse the sample cost
- 10 vials per box.
- Australia North America South America Western Europe
Product Description
Retatrutide is an active compound released by Eli Lilly in June 2023. It is a triple (GLP-1/GIP/Gcg) agonist based on the GLP/GI dual receptor agonist Tirzepatide through a hybrid glucagon (GlucagonGcg) related structure, and is a drug for the treatment of obesity and type 2 diabetes. This active compound can activate receptor agonists in our body, which helps control blood sugar and weight loss management.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Peptide Preparations' category
Quick Inquiry
Contact Details
DALIAN HANDOM CHEMICALS CO.,LTD.
RM702, Unit 1, Building 21, Liuhe Road, Ganjingzi Dist,Dalian - 116091, Liaoning, China
Phone :--+8615840669648
Send InquiryE-mail us : export@handom-chem.com
 |
DALIAN HANDOM CHEMICALS CO.,LTD.
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |
